Modelling the impact of antimalarial quality on the transmission of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum

BACKGROUND: The use of poor quality antimalarial medicines, including the use of non-recommended medicines for treatment such as sulfadoxine-pyrimethamine (SP) monotherapy, undermines malaria control and elimination efforts. Furthermore, the use of subtherapeutic doses of the active ingredient(s) ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Brock, Aleisha R., Ross, Joshua V., Greenhalgh, Scott, Durham, David P., Galvani, Alison, Parikh, Sunil, Esterman, Adrian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001968/
https://www.ncbi.nlm.nih.gov/pubmed/29928735
http://dx.doi.org/10.1016/j.idm.2017.04.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001968/
https://www.ncbi.nlm.nih.gov/pubmed/29928735
http://dx.doi.org/10.1016/j.idm.2017.04.001

Ejemplares similares